Filing Details
- Accession Number:
- 0000937556-25-000045
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-12 20:05:51
- Reporting Period:
- 2025-03-10
- Filing Date:
- 2025-03-12
- Accepted Time:
- 2025-03-12 20:05:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 937556 | Masimo Corp | MASI | Electromedical & Electrotherapeutic Apparatus (3845) | 330368882 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1734507 | Bilal Muhsin | C/O Masimo Corporation 52 Discovery Irvine CA 92618 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-10 | 30,000 | $37.84 | 54,172 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-03-10 | 2,400 | $163.28 | 51,772 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-10 | 3,935 | $165.18 | 47,837 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-10 | 10,087 | $166.03 | 37,750 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-10 | 1,436 | $166.71 | 36,314 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-10 | 1,700 | $167.97 | 34,614 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-10 | 1,761 | $169.37 | 32,853 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-10 | 6,965 | $170.86 | 25,888 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-10 | 1,716 | $171.76 | 24,172 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2025-03-10 | 30,000 | $37.84 | 30,000 | $37.84 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-02-28 | 2026-02-28 | No | 4 | M | Direct |
Footnotes
- Sales were effected in transactions intended to satisfy the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
- The price reported in Column 4 represents the weighted average purchase price per share. The actual sale prices ranged from a low of $162.99 per share to a high of $163.80 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- The price reported in Column 4 represents the weighted average purchase price per share. The actual sale prices ranged from a low of $164.62 per share to a high of $165.61 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- The price reported in Column 4 represents the weighted average purchase price per share. The actual sale prices ranged from a low of $165.62 per share to a high of $166.61 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- The price reported in Column 4 represents the weighted average purchase price per share. The actual sale prices ranged from a low of $166.62 per share to a high of $166.89 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- The price reported in Column 4 represents the weighted average purchase price per share. The actual sale prices ranged from a low of $170.47 per share to a high of $171.43 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- The price reported in Column 4 represents the weighted average purchase price per share. The actual sale prices ranged from a low of $171.47 per share to a high of $172.46 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- This option was granted on February 29, 2016 and was exercisable as the option vested. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
Billionaire Hedge Funds
